Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the ...
- SION-719 and SION-451, combined with complementary CFTR modulators, fully restore ΔF508-CFTR maturation, trafficking, and function to wild-type levels in CFHBE model and other preclinical systems - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback